Literature DB >> 3850846

Haplotype study on C4 polymorphism in Japanese. Associations with MHC alleles, complotypes, and HLA-complement haplotypes.

K Tokunaga, K Omoto, T Akaza, N Akiyama, H Amemiya, S Naito, T Sasazuki, H Satoh, T Juji.   

Abstract

Genetic polymorphism of the fourth component of human complement (C4) was investigated in 83 Japanese families which have been typed for HLA-A,-B,-C,-DR, C2, and BF. Four common C4A alleles and four common C4B alleles were observed. The allele frequencies estimated from unrelated parents were as follows: C4A3, 0.686; A4, 0.132; A2, 0.106; AQ0, 0.067; ARares, 0.009; C4B1, 0.587; B2, 0.167; B5, 0.088; and BQ0, 0.158. Eight different C4 haplotypes were observed with frequencies of more than 0.01. The estimated haplotype frequencies were as follows: C4A3-B1, 0.513; A4-B2, 0.114; A2-BQ0, 0.106; A3-B5, 0.088; AQ0-B1, 0.059; A3-BQ0, 0.047; A3-B2, 0.038; A4-B1, 0.015; and Rares, 0.021. Strong positive gametic associations were found in the following C4-HLA haplotypes: C4A2BQ0-A24, C4A2BQ0-Bw52, C4A3B5-Bw54, C4A3B5-Bw59, C4A4B2-Bw46, C4A3B5-Cw1, C4A2BQ0-DR2, and C4A3B5-DR4. Eleven complotypes were observed with frequencies of more than 0.01. C4A2BQ0 and C4A3B5 were exclusively associated with BFS-C2C. BFF was associated with C4A3B1. C2AT, C2B, and C2BH were associated with C4A3B1, A4B2, and C4A3B1, respectively. Eight different HLA-complement haplotypes were found to be characteristic of Japanese. These combinations are considerably different from those reported in Caucasoid populations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3850846     DOI: 10.1007/bf00430919

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  20 in total

1.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms.

Authors:  J Dausset; L Legrand; V Lepage; L Contu; A Marcelli-Barge; I Wildloecher; A Benajam; T Meo; L Degos
Journal:  Tissue Antigens       Date:  1978-10

3.  Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes.

Authors:  C Rittner; C M Giles; M H Roos; P Démant; E Mollenhauer
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Study of alleles of the second complement component (C2) on Canadian HLA haplotypes.

Authors:  W H Marshall; J M Barnard; D Churchill; N R Farid; R Grandy; B Larsen; R H Payne; V M Skanes; G C Ebers; D W Paty
Journal:  Tissue Antigens       Date:  1984-04

5.  Disease associations with complotypes, supratypes and haplotypes.

Authors:  R L Dawkins; F T Christiansen; P H Kay; M Garlepp; J McCluskey; P N Hollingsworth; P J Zilko
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  Statement on the nomenclature of human C4 allotypes.

Authors:  G Mauff; C A Alper; Z Awdeh; J R Batchelor; J Bertrams; G Bruun-Petersen; R L Dawkins; P Démant; J Edwards; H Grosse-Wilde; G Hauptmann; P Klouda; L Lamm; E Mollenhauer; C Nerl; B Olaisen; G O'Neill; C Rittner; M H Roos; V Skanes; P Teisberg; L Wells
Journal:  Immunobiology       Date:  1983-03       Impact factor: 3.144

7.  Serum complement 'supergenes' of the major histocompatibility complex in man (complotypes).

Authors:  C A Alper; D Raum; S Karp; Z L Awdeh; E J Yunis
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

8.  MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and associations with distinct HLA haplotypes in German Caucasians.

Authors:  D J Schendel; G J O'Neill; R Wank
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  The C4 beta-chain: evidence for a genetically determined polymorphism.

Authors:  G Mauff; M Steuer; M Weck; K Bender
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

View more
  7 in total

1.  The genomic structure of two ancestral haplotypes carrying C4A duplications.

Authors:  K Tokunaga; W J Zhang; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis.

Authors:  H Nakagawa; S Akazaki; A Asahina; K Tokunaga; K Matsuki; S Kuwata; Y Ishibashi; T Juji
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  HLA-G gene polymorphism in a Japanese population.

Authors:  T Yamashita; T Fujii; Y Watanabe; K Tokunaga; K Tadokoro; T Juji; Y Taketani
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex.

Authors:  Erwin K Chung; Yan Yang; Robert M Rennebohm; Marja-Liisa Lokki; Gloria C Higgins; Karla N Jones; Bi Zhou; Carol A Blanchong; C Yung Yu
Journal:  Am J Hum Genet       Date:  2002-09-11       Impact factor: 11.025

5.  HLA haplotypes with C4B5; evidence for further allelic heterogeneity.

Authors:  S N Hing; C M Giles; A H Fielder; J R Batchelor
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles.

Authors:  C Y Yu; R D Campbell
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis.

Authors:  I Dunham; C A Sargent; R L Dawkins; R D Campbell
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.